BCM
CLMT icon

BlueCrest Capital Management’s Calumet Specialty Products CLMT Stock Holding History

BlueCrest Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,000
Closed -$11K – 252
2020
Q1 		$11K Buy
+10,000
New +$33.8K ﹤0.01% 210

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

BlueCrest Capital Management's CLMT Position: Q1 2026 in Review

BlueCrest Capital Management increased its Calumet Specialty Products (CLMT) stake by 50% in Q1 2026, buying an estimated $518K and bringing the position to 60,000 shares worth $2.15M. The position accounts for 0.13% of the portfolio, ranked #142.

BlueCrest Capital Management first reported a position in CLMT in Q3 2024 and has held it in 7 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • BlueCrest Capital Management held 60,000 shares of Calumet Specialty Products worth $2.15M as of Q1 2026.
  • BlueCrest Capital Management bought 20,000 Calumet Specialty Products shares in Q1 2026, an estimated $518K.
  • Calumet Specialty Products made up 0.13% of BlueCrest Capital Management's portfolio in Q1 2026, its #142 holding.
  • BlueCrest Capital Management first reported a position in Calumet Specialty Products in Q3 2024 and has held it in 7 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on BlueCrest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.